Cargando…
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
International guidance on chronic obstructive pulmonary disease (COPD) management recommends the use of inhaled corticosteroids (ICS) in those patients at increased likelihood of exacerbation. In spite of this guidance, ICS are prescribed in a large number of patients who are unlikely to benefit. Gi...
Autores principales: | Yawn, Barbara P, Suissa, Samy, Rossi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042192/ https://www.ncbi.nlm.nih.gov/pubmed/27684954 http://dx.doi.org/10.1038/npjpcrm.2016.68 |
Ejemplares similares
-
Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary
Disease: Can IMPACT Help?
por: Suissa, Samy
Publicado: (2020) -
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
por: Rossi, Andrea, et al.
Publicado: (2014) -
Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019) -
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)